4 results on '"Guang-Hui Qian"'
Search Results
2. MiR-223-3p Alleviates Vascular Endothelial Injury by Targeting IL6ST in Kawasaki Disease
- Author
-
Xiang Wang, Yue yue Ding, Ye Chen, Qiu qin Xu, Guang hui Qian, Wei guo Qian, Lei Cao, Wan ping Zhou, Miao Hou, and Hai tao Lv
- Subjects
Agonist ,medicine.medical_specialty ,medicine.drug_class ,030204 cardiovascular system & hematology ,Pediatrics ,STAT3 ,03 medical and health sciences ,0302 clinical medicine ,mir-223 ,030225 pediatrics ,Internal medicine ,microRNA ,medicine ,vascular endothelial damage ,Original Research ,Messenger RNA ,Kawasaki disease ,biology ,business.industry ,Activator (genetics) ,lcsh:RJ1-570 ,lcsh:Pediatrics ,medicine.disease ,Blot ,Endocrinology ,Pediatrics, Perinatology and Child Health ,biology.protein ,business ,MicroRNA-223-3p ,IL6ST - Abstract
Background: Kawasaki disease (KD) is a self-limiting illness with acute systematic vascular inflammation. It causes pathological changes in mostly medium and small-sized arteries, especially the arteria coronaria, which adds the risk of developing coronary heart disease in adults. Materials and methods: We detected the miR-223-3p expression in 30 KD patients combined with 12 normal controls using miRNA microarrays and RT-PCR. A KD mouse model was constructed using Candida albicans water insoluble substance (CAWS). We also checked the miR-223-3p's expression using qRT-PCR. The Luciferase reporting system was implemented to validate the correlation between miR-223-3p and Interleukin-6 receptor subunit beta (IL-6ST). TNF-α was used to stimulate human coronary artery endothelial cells (HCAECs), and miR-223-3p activator or inhibitor and KD serum were used to treat HCAECs. A Western blotting automatic quantitative analysis protein imprinting system was used to test the expression of signal transducer and the activator of transcription 3 (STAT3), phosphorylated-signal transducer and the activator of transcription 3 (pSTAT3) and NF-κB p65. Results: Clinical trials found that miR-223-3p expressions were markedly different (more than 2-fold) between the acute KD group and the control group. E-selectin and intercellular cell adhesion molecule-1 (ICAM-1) levels were also significantly higher (about 2-fold) in KD especially with coronary artery lesions. MiR-223-3p could alleviate vascular endothelial damage in KD mice, and IL-6 (Interleukin-6), E-selectin and ICAM-1 were simultaneously negative. The values of IL-6, E-selectin, and ICAM-1 mRNA expressions decreased, while the value of IL-6ST was increased between the agonist treated mice and KD mice. The RT-qPCR consequences displayed that miR-223-3p explored the highest expression on the third day in both the KD mice as well as the agonist group. MiR-223-3p can directly combine with IL-6ST 3' untranslatable regions (UTR) and held back the IL-6's expression. Overexpression of miR-223 down regulated IL6ST expression and decreased the expression of p-STAT3 and NF-κB p65, while the miR-223 inhibitor could reverse the above process. Conclusion: MiR-223-3p is an important regulatory factor of vascular endothelial damage in KD and could possibly become a potential target of KD treatment in the future.
- Published
- 2019
3. Molecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells
- Author
-
Jian Pan, Jian Wang, Na-Na Wang, Xing Feng, Yan-Fang Tao, Zhi-Heng Li, Yunyun Xu, Yi Wu, Guang-Hui Qian, Li-Xiao Xu, Mei Li, Xiaolu Li, Jun Lu, Junli Ren, Wei-Wei Du, Wei-Qi He, Fang Fang, Yanhong Li, Yi-Ping Li, and Shaoyan Hu
- Subjects
0301 basic medicine ,Senescence ,Cancer Research ,Cell ,Biology ,Cellular senescence ,Arraystar Human LncRNA array ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Genetics ,CDK4/6 ,LEE011 ,Propidium iodide ,Acute leukemia ,Leukemia ,Cell growth ,Cell cycle ,medicine.disease ,Cell biology ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,Oncology ,030220 oncology & carcinogenesis ,biology.protein ,Cyclin-dependent kinase 6 ,Primary Research - Abstract
Background Overexpression of cyclin D1 dependent kinases 4 and 6 (CDK4/6) is a common feature of many human cancers including leukemia. LEE011 is a novel inhibitor of both CDK4 and 6. To date, the molecular function of LEE011 in leukemia remains unclear. Methods Leukemia cell growth and apoptosis following LEE011 treatment was assessed through CCK-8 and annexin V/propidium iodide staining assays. Cell senescence was assessed by β-galactosidase staining and p16INK4a expression analysis. Gene expression profiles of LEE011 treated HL-60 cells were investigated using an Arraystar Human LncRNA array. Gene ontology and KEGG pathway analysis were then used to analyze the differentially expressed genes from the cluster analysis. Results Our studies demonstrated that LEE011 inhibited proliferation of leukemia cells and could induce apoptosis. Hoechst 33,342 staining analysis showed DNA fragmentation and distortion of nuclear structures following LEE011 treatment. Cell cycle analysis showed LEE011 significantly induced cell cycle G1 arrest in seven of eight acute leukemia cells lines, the exception being THP-1 cells. β-Galactosidase staining analysis and p16INK4a expression analysis showed that LEE011 treatment can induce cell senescence of leukemia cells. LncRNA microarray analysis showed 2083 differentially expressed mRNAs and 3224 differentially expressed lncRNAs in LEE011-treated HL-60 cells compared with controls. Molecular function analysis showed that LEE011 induced senescence in leukemia cells partially through downregulation of the transcriptional expression of MYBL2. Conclusions We demonstrate for the first time that LEE011 treatment results in inhibition of cell proliferation and induction of G1 arrest and cellular senescence in leukemia cells. LncRNA microarray analysis showed differentially expressed mRNAs and lncRNAs in LEE011-treated HL-60 cells and we demonstrated that LEE011 induces cellular senescence partially through downregulation of the expression of MYBL2. These results may open new lines of investigation regarding the molecular mechanism of LEE011 induced cellular senescence. Electronic supplementary material The online version of this article (doi:10.1186/s12935-017-0405-y) contains supplementary material, which is available to authorized users.
- Published
- 2017
4. Wnt signaling pathway and the Evo-Devo of deuterostome axis
- Author
-
Yi-Quan Wang and Guang-Hui Qian
- Subjects
Regulation of gene expression ,Genetics ,Deuterostome ,Beta-catenin ,biology ,Wnt signaling pathway ,LRP6 ,LRP5 ,General Medicine ,biology.organism_classification ,Cell biology ,biology.protein ,Gene family ,Zebrafish - Abstract
A series of signal transduction pathways have been found to regulate the polarity establishment and formation of animal primary body axis. Among them, Wnt signaling pathway is extremely conserved and several key components in the pathway have been identified in the demosponge lineage. This implies that it is one of the earliest pathways involved in the ancestral metazoan axis development and might play an important role in specification and development of posterior and ventral fate of animal axis. Recently, with the establishment of functional experiments in vitro, the body plan formation has been found to be affected, in varying degrees, by many genes in the Wnt signaling pathway, such as members of wnt gene family, maternal gene beta-catenin and some transcription factor encoding genes. In this review, we analyzed the evolutionary origin of the wnt gene family involved in development of metazoan body plans, and then made a brief review on the roles of canonical Wnt/beta-catenin signaling in the polarity establishment and formation of primary body axis in diverse deuterostomes including sea urchin, amphioxus, zebrafish, frog, and mouse.
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.